Ubrogepant(CAS: 1374248-77-7)

Ubrogepant is a selective CGRP receptor antagonist used for the acute treatment of migraine with or without aura in adults. This compound has a molecular formula of C21H25N3O2 and is known for its analgesic properties.

Ubrogepant is primarily used in the acute treatment of migraine with or without aura. It is a prescription medication that provides fast relief to migraine sufferers by blocking the calcitonin gene-related peptide (CGRP), a key player in migraine pain.

Ubrogepant is considered safe when used as prescribed. However, it is important to follow the doctor's instructions and be aware of potential side effects such as nausea, dizziness, and dysgeusia. Patients should avoid driving or operating heavy machinery if experiencing dizziness.

Ubrogepant should be stored at room temperature (15°C to 30°C or 59°F to 86°F), away from direct sunlight and moisture. It should be kept in a tightly closed container and protected from light and excessive humidity to maintain its efficacy.